Breast screening programme saves 1,400 lives per year.

NHS Cancer Screening Programme Logo
Feedback and Enquires to the NHS Cancer Screening Programmes
NHS Cancer Screening
NHS Cancer Screening Press Room
NHS Breast Screening Programme
NHS Cervical Screening Programme
NHS Bowel Cancer Screening Programme
NHS Prostate Cancer Risk Management

Breast Screening Annual Review (UK)
Breast screening statistics
Breast Screening Equipment Guidance

Research Literature Online Database

Published 22nd February, 2006

Screening for Breast Cancer in England: Past and Future

A new report published today estimates that the NHS Breast Screening Programme is saving 1,400 lives every year in England. This comprehensive review of the screening programme shows that women who attend for screening are not only less likely to die from breast cancer, but also less likely to be treated with a mastectomy than those who are not screened.

The purpose of the report, 'Screening for Breast Cancer in England: Past and Future' was to review all available evidence on the benefits and risks associated with the NHS Breast Screening Programme and to draw firm conclusions about its effectiveness.

Julietta Patnick CBE, Director, NHS Cancer Screening Programmes says, "I am delighted that these findings recognise the huge contribution the programme is making to women's lives. Breast screening is effective in combating this very common disease. I hope the report will encourage women to make an informed choice to attend for screening when invited."

The Chair of the Advisory Committee on Breast Cancer Screening which produced the report is Professor Valerie Beral, Director of the Cancer Research UK Epidemiology Unit at Oxford University. She says, "Our findings clearly show that, for women aged 50 and over, breast screening can save lives. By detecting breast cancer earlier it also provides many women with improved outcomes, reducing the likelihood that they will need to undergo invasive treatments such as mastectomies. The value of breast screening has been debated and we have carefully evaluated both its advantages and disadvantages. The available evidence undoubtedly demonstrates that the benefits of the programme greatly outweigh any risks."

The report's findings are based on a review of all areas of the breast screening programme including: efficacy, treatment, technological developments, age and frequency of screening, costs, communication with women and attendance for screening. Evidence is considered from the worldwide literature and applied to the actual experience of the breast screening programme in this country.


Search this site for:
Breast Screening Publications Index

Breast screening programme index

What happens at a
breast screening unit?

What are the risks of breast screening?

Frequently Asked Questions (FAQs)

Breast awareness

Benign breast disease

DCIS (Ductal Carcinoma
in Situ)

Diethylstilbestrol (DES) exposed women

Breast cancer

Quality assurance

Training

Programme statistics

Archived statistics bulletins

Research

Publications

Programme posters

Archive

Useful links

Home | Breast Screening | Cervical Screening | Bowel Cancer Screening | Prostate Cancer Risk Management | Breast Screening News | Contact NHS Screening ]

The national office can be contacted at:

NHS Cancer Screening Programmes
Fulwood House
Old Fulwood Road
SHEFFIELD S10 3TH

Tel: 0114 271 1060
Fax: 0114 271 1089
E-mail: [email protected]

Press and media enquiries should be made to:

NHS Cancer Screening Press Office
100 Gray's Inn Road
London
WC1X 8AL

Tel: 020 7400 4499
Fax: 020 7400 4481
E-mail: [email protected]

breastscreen/news/027.html
Designed and hosted by The Net Effect
©NHS Cancer Screening Programmes